在加拿大
“合规性”如何地道的翻译？
评论
人生何处不相逢，与人为善，乐事也！ 赏 2007-03-15#2 A 1,889 $0.00 如果是表示符合某个标准或规定，可以用 compliance
评论
COMPLIANCE 主要是指符合法律，用REGULARITY呢？
评论
人生何处不相逢，与人为善，乐事也！COMPLIANCE 主要是指符合法律，用REGULARITY呢？点击展开...觉得你要的应该是conformity ( correspondence in form, manner, or character )conformity certificate 指合格证.Compliance 应该也可以，算和 Conformity 近义。但也有区别，觉得更强调过程。比如对指对规定和特性的严格conformity.Regularity应该不太合适。不过如果有语境的话，可能回答起来更方便些
评论
改变自己总比改变他人要难！http://www.qingshen.de 赏 2007-03-17#5
140 $0.00 Can you give a sentence?评论
Saber 说:觉得你要的应该是conformity ( correspondence in form, manner, or character )conformity certificate 指合格证. Compliance 应该也可以，算和 Conformity 近义。但也有区别，觉得更强调过程。比如对指对规定和特性的严格conformity. Regularity应该不太合适。不过如果有语境的话，可能回答起来更方便些点击展开...谢谢指点，是这样的，一位朋友要做一个关于公司内部管理和运作合规性的英文报告，不知用哪个词较好？
评论
人生何处不相逢，与人为善，乐事也！ 赏 2007-03-17#7 满
Guest
上市公司有Corporate Compliance一说评论
谢谢楼上的朋友，我知道compliance主要是用于对国家法规的一致性描述，我这里的合规性还包括对公司内部规定的一致性定义，真不知哪个词比较恰当。有没有朋友做过“合规经理”类似的position?
评论
人生何处不相逢，与人为善，乐事也！上市公司有Corporate Compliance一说点击展开...Ding！
评论
http://www.bit.ly/lugordon看世界的脚步 。。。登陆多伦多的红宝书 赏 2007-03-17#10 P 200 $0.00 上市公司的auditing report 就有internal contral compliance report.for instance: The Federal Managers' Financial Integrity Act of 1982 requires an annual evaluation of agency systems of internal accounting and administrative control to determine if such systems are in compliance with certain requirements related to costs and obligations, assets, revenues and expenses.
评论
满囤 说:上市公司有Corporate Compliance一说点击展开...很好奇 Corporate Compliance 中文应该翻译成什么。见过有“法人遵从”的说法，但一直觉得这个翻译怪怪的。
评论
Alien 说:很好奇 Corporate Compliance 中文应该翻译成什么。见过有“法人遵从”的说法，但一直觉得这个翻译怪怪的。点击展开...企业合规，如何？
评论
http://www.bit.ly/lugordon看世界的脚步 。。。登陆多伦多的红宝书谢谢楼上的朋友，我知道compliance主要是用于对国家法规的一致性描述，我这里的合规性还包括对公司内部规定的一致性定义，真不知哪个词比较恰当。有没有朋友做过“合规经理”类似的position?点击展开...我们公司里有一个职位，名片上是这样印的： Abcd EfghVice PresidentCorporate Compliance 中文如何翻译倒确实没有找到合适的词。
评论
我认为就是Compliance。
评论
满囤 说:我们公司里有一个职位，名片上是这样印的： Abcd EfghVice PresidentCorporate Compliance 中文如何翻译倒确实没有找到合适的词。点击展开... B. COMPLIANCE COMMITTEE & COMPLIANCE OFFICER 1. Compliance Committee The Board of Directors chartered a Compliance Committee of the Board of Directors (the “Compliance Committee”) on May 22, 2003, which assists the Board in overseeing the compliance by MedImmune with laws and regulations relating to the research, development, manufacture and marketing of the company’s products. To that end, the Compliance Committee is responsible for overseeing the development, implementation, administration and enforcement of MedImmune’s compliance programs. The Compliance Committee meets regularly and receives regular reports from the Compliance Officer. 2. Corporate Compliance Officer MedImmune’s Chief Executive Officer shall appoint a Corporate Compliance Officer (“CCO”).4The CCO shall be a person with appropriate authority and power and will be sufficiently educated and trained and shall be responsible for overseeing and enforcing all The Code of Conduct may be revised from time to time in order to address changes in the industry and MedImmune’s operations, as well as the laws, regulations, rules and standards concerning these changes. All MedImmune personnel are responsible for complying with the most recent version of the Code of Conduct and all laws, regulations, rules and standards applicable to MedImmune. Each copy of the Code of Conduct will specify the version of the document and the date of the most recent review of the Code. 4The identity of the CCO shall be disseminated to all Personnel in conjunction with the dissemination of this Compliance Program at the time of hiring, and shall be publicized periodically at training sessions, in conspicuous postings, and in MedImmune’s i3nternal publications.
评论
aspects of the Compliance Program. The identity and contact information of the CCO shall be publicized throughout MedImmune. The current CCO is William C. Bertrand, Jr., Vice President, General Counsel and Corporate Compliance Officer. The CCO shall ensure the uniform implementation of the Compliance Program and will coordinate with legal counsel (“Counsel”) as set forth in this Compliance Program Description. In addition, the CCO shall: • coordinate personnel issues with Human Resources, such as the review of the HHS-Office of Inspector General (OIG) List of Excluded Individuals; • assist MedImmune’s internal auditors in coordinating internal compliance reviews and monitoring activities; • as appropriate, review and act in response to reports of non-compliance received from the hotline or otherwise brought to the CCO’s attention; • independently investigate matters related to compliance, and have the authority to design and coordinate internal investigations and any corrective action with various MedImmune departments; • participate with Counsel in the appropriate reporting of any self-discovered violations of federal health care program requirements; and • revise or expand the compliance program, as appropriate. The CCO has authority to review all documents and other information relevant to compliance related activities, including the authority to examine all interactions with government programs to determine if MedImmune is in compliance with federal health care program reporting and rebate requirements and to examine interactions with health care professionals that could violate federal health care program requirements. The CCO shall also keep the Compliance Committee informed of developments in the Compliance Program. Following this Compliance Program Description’s adoption by the Compliance Committee, the CCO shall distribute to all current MedImmune personnel an introductory letter from that summarizes the Compliance Program, and explains its importance.
评论
谢谢!
评论
BEIJING2008,THANK YOU VERY MUCH.
评论
人生何处不相逢，与人为善，乐事也！aspects of the Compliance Program. The identity and contact information of the CCO shall be publicized throughout MedImmune. The current CCO is William C. Bertrand, Jr., Vice President, General Counsel and Corporate Compliance Officer. The CCO shall ensure the uniform implementation of the Compliance Program and will coordinate with legal counsel (“Counsel”) as set forth in this Compliance Program Description. In addition, the CCO shall: • coordinate personnel issues with Human Resources, such as the review of the HHS-Office of Inspector General (OIG) List of Excluded Individuals; • assist MedImmune’s internal auditors in coordinating internal compliance reviews and monitoring activities; • as appropriate, review and act in response to reports of non-compliance received from the hotline or otherwise brought to the CCO’s attention; • independently investigate matters related to compliance, and have the authority to design and coordinate internal investigations and any corrective action with various MedImmune departments; • participate with Counsel in the appropriate reporting of any self-discovered violations of federal health care program requirements; and • revise or expand the compliance program, as appropriate. The CCO has authority to review all documents and other information relevant to compliance related activities, including the authority to examine all interactions with government programs to determine if MedImmune is in compliance with federal health care program reporting and rebate requirements and to examine interactions with health care professionals that could violate federal health care program requirements. The CCO shall also keep the Compliance Committee informed of developments in the Compliance Program. Following this Compliance Program Description’s adoption by the Compliance Committee, the CCO shall distribute to all current MedImmune personnel an introductory letter from that summarizes the Compliance Program, and explains its importance.点击展开...看晕
评论
compliance没问题。外资银行都有Compliance Department, 中文即为合规部门。
·中文新闻 “大吃一惊”：为 Bianca Jones 和 Holly Bowles 的家人筹款一夜超过
·中文新闻 墨尔本大雾笼罩，导致路况危险，塔拉马林机场航班取消